H. Verspaget

R. van Hillegersberg, P. Siersema, G. Beets, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Tetranectin expression in human colonic neoplasia

H. Verspaget, I. Clemmensen, S. Ganesh, 1994, Histopathology.

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis.

P. Quax, H. Verspaget, Cornelis F. M. Sier, 1991, Gastroenterology.

Plasminogen Activators and Gastrointestinal Neoplasms

H. Verspaget, G. Griffioen, J. Verheijen, 1989 .

In vivo and in vitro invasion in relation to phenotypic characteristics of human colorectal carcinoma cells.

M. Mareel, W. Dinjens, A. D. de Bruïne, 1995, British Journal of Cancer.

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients

E. Olofsen, H. Verspaget, J. Swen, 2015, European Journal of Clinical Pharmacology.

Endothelium specific matrilysin (MMP-7) expression in human cancers.

G. Kenter, H. Verspaget, Valérie Ferreira, 2007, Matrix biology : journal of the International Society for Matrix Biology.

Solitary and synchronous adenomas of the colon and rectum: comparison of malignancy parameters

H. Verspaget, F. Bosman, G. Griffioen, 1990, Histopathology.

The expression of carcinoembryonic antigen and secretory component in adenomas of the human colon and rectum

H. Verspaget, F. Bosman, G. Griffioen, 1989, Diseases of the colon and rectum.

Plasminogen activator profiles in neoplastic tissues of the human colon.

H. Verspaget, G. Griffioen, J. Verheijen, 1988, Cancer research.

Effect of oral zinc supplementation on metallothionein and superoxide dismutase concentrations in patients with inflammatory bowel disease

H. Verspaget, G. Griffioen, C. Lamers, 1994, Journal of gastroenterology and hepatology.

4 ROLE OF TUMOR NECROSIS FACTOR-α AND INTERLEUKIN-10 GENE POLYMORPHISMS IN IRRITABLE BOWEL SYNDROME

H. Verspaget, A. Masclee, M. V. D. Berg, 2009 .

Role of Tumor Necrosis Factor-α and Interleukin-10 Gene Polymorphisms in Irritable Bowel Syndrome

H. Verspaget, A. Masclee, M. V. D. Berg, 2005, The American Journal of Gastroenterology.

Suppression of intestinal mucosal natural killer cells by corticosteroids

H. Verspaget, G. Griffioen, C. Lamers, 1997, Alimentary pharmacology & therapeutics.

Familial adenomatous polyposis: from bedside to bench and vice versa

H. Verspaget, G. Griffioen, C. Lamers, 1999, Cytogenetic and Genome Research.

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma.

H. Verspaget, S. Ganesh, F. Kubben, 1996, British Journal of Cancer.

Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.

D. Hommes, J. Hoogenboom, H. Morreau, 2014, Gastroenterology.

Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.

H. Verspaget, Zhen Liu, P. ten Dijke, 2010, Cancer research.

Tumor and Stem Cell Biology Cancer Research Matrix Metalloproteinase-14 ( MT 1-MMP ) – Mediated Endoglin Shedding Inhibits Tumor Angiogenesis

H. Verspaget, P. Dijke, Zhen Liu, 2010 .

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

H. Verspaget, L. Kruidenier, 1998, Mediators of inflammation.

Role of matrix metalloproteinase,tissue inhibitor of metalloproteinase and tumor necrosis factor-α single nucleotide gene polymorphisms in inflammatory bowel disease

D. Hommes, H. Verspaget, C. Lamers, 2007 .

Cancer Caspase-3 Activity Predicts Local Recurrence in Rectal

H. Putter, C. Marijnen, P. Kuppen, 2019 .

Caspase-3 Activity Predicts Local Recurrence in Rectal Cancer

H. Putter, C. Marijnen, P. Kuppen, 2007, Clinical Cancer Research.

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis

M. Goumans, H. Verspaget, B. van Hoek, 2021, Cells.

Urokinase receptor and colorectal cancer survival

H. Verspaget, S. Ganesh, G. Griffioen, 1994, The Lancet.

Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors.

H. Verspaget, C. Lamers, L. Hawinkels, 2011, World journal of gastroenterology.

Chapter 5 Interaction between colon cancer cells and fibroblasts generates myofibroblasts via activation of Transforming Growth Factor-1

D. Hommes, H. Verspaget, P. Dijke, 2009 .

5-Aminosalicylic acid inhibits TGF-beta1 signalling in colorectal cancer cells.

D. Hommes, H. Verspaget, C. Lamers, 2010, Cancer letters.

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.

P. Quax, H. Verspaget, U. Weidle, 1994, The American journal of pathology.

Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?

H. Verspaget, R. V. van Hogezand, 1996, The Netherlands journal of medicine.

Active TGF‐β1 correlates with myofibroblasts and malignancy in the colorectal adenoma‐carcinoma sequence

D. Hommes, H. Verspaget, Cornelis F. M. Sier, 2009 .

Chapter 4 Active TGF-1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence

D. Hommes, H. Verspaget, J. Verheijen, 2009 .

Matrix Metalloproteinases in Chronic Liver Disease and Liver Transplantation

H. Verspaget, B. Hoek, J. Kuyvenhoven, 2006 .

Fecal microbiota transplantation is associated with improved aspects of mental health of patients with recurrent Clostridioides difficile infections.

E. Giltay, E. Kuijper, J. Keller, 2022, Journal of Affective Disorders Reports.

Fecal Lysozyme in Assessment of Disease Activity in Inflammatory Bowel Disease

H. Verspaget, C. Lamers, I. Biemond, 1998, Digestive Diseases and Sciences.

Glutathione S-transferase pi in colorectal tumors is predictive for overall survival.

H. Verspaget, S. Ganesh, Cornelis F. M. Sier, 1995, Cancer research.

A Thirty-Year Follow-Up Surveillance Study for Neoplasia of a Dutch Ulcerative Colitis Cohort

H. Verspaget, R. Veenendaal, R. V. van Hogezand, 2013, TheScientificWorldJournal.

High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death

Michael E. Sutton, H. Verspaget, R. Porte, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Low prevalence of Helicobacter pylori infection in young children in the Netherlands

B. Mertens, H. Verspaget, P. Mourad-Baars, 2007, European journal of gastroenterology & hepatology.

H. Verspaget, G. Griffioen, C. Lamers, 1990, Free radical biology & medicine.

Erratum: Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 (Nature Genetics (2011) 43 (246-252))

Judy H. Cho, M. Daly, R. Ophoff, 2011 .

Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury.

C. Allen, H. Verspaget, H. Ashktorab, 2000, Carcinogenesis.

Gastric mucosal plasminogen activators inHelicobacter pylori infection

Y. Vergouwe, H. Verspaget, C. Lamers, 1996, Digestive Diseases and Sciences.

Gastric mucosal superoxide dismutases in Helicobacter pylori infection.

H. Verspaget, C. Lamers, I. Biemond, 1996, Gut.

The effect of treatment of Helicobacter pylori infection on gastric mucosal plasminogen activators

H. Verspaget, C. Lamers, R. Veenendaal, 1996 .

Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease.

H. Verspaget, D. Taylor, C. Lamers, 1997, Scandinavian journal of gastroenterology.

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

C. V. D. van de Velde, H. Verspaget, S. Ganesh, 1996, Cancer.

Eradication of Helicobacter pylori Infection Favourably Affects Altered Gastric Mucosal MMP-9 Levels

H. Verspaget, M. Schram, F. Kubben, 2007 .

CHAPTER 3 Eradication of Helicobacter pylori infection favourably a ects altered gastric mucosal MMP-9 levels

H. Verspaget, M. Schram, F. Kubben, 2007 .

Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer.

C. Bosman, C. V. D. van de Velde, H. Verspaget, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.

H. Verspaget, C. Lamers, R. Veenendaal, 1997, Gut.

An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.

H. Verspaget, C. Lamers, I. Biemond, 2011, The Netherlands journal of medicine.

CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations

J. Holstege, H. Verspaget, D. Jaarsma, 2001, Acta Neuropathologica.

Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis

D. Troost, H. Verspaget, H. Blaauwgeers, 1996, Journal of the Neurological Sciences.

Chapter 2 Expression of Matrix Metalloproteinases-2 and-9 in Intestinal Tissue of Patients with Inflammatory Bowel Disease ( IBD ) Short title : gelatinases in IBD

H. Verspaget, Q. Gao, F. Kubben, 2009 .

Chapter 6 Expression of matrix metalloproteinases ( M M P )-2 and M M P-9 in intestinal tissue of patients with inflammatory bowel diseases ( IBD ) Short title : MMPs in IBD

H. Verspaget, Q. Gao, F. Kubben, 2005 .

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.

H. Verspaget, M. Meijer, Q. Gao, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease

H. Verspaget, C. Lamers, L. Kruidenier, 2003, The Journal of pathology.

Metallothionein in amyotrophic lateral sclerosis.

D. Troost, H. Verspaget, P. S. Sillevis Smitt, 1994, Biological signals.

5‐aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes

D. Hommes, H. Verspaget, C. Lamers, 2010, Inflammatory bowel diseases.

Copper-zinc superoxide dismutase in cerebrospinal fluid: implications for oxygen-radical stress in the central nervous system

R. Roos, H. Verspaget, P. Laboyrie, 1992, Clinical Neurology and Neurosurgery.

Immunomodulatory Effects of Mesenchymal Stromal Cells in Crohn's Disease

D. Hommes, H. Verspaget, I. Molendijk, 2012, Journal of allergy.

Decrease in two intestinal copper/zinc containing proteins with antioxidant function in inflammatory bowel disease.

H. Verspaget, C. Lamers, A. Peña, 1991, Gut.

Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review.

H. Verspaget, C. Lamers, A. Peña, 1991, Scandinavian journal of gastroenterology. Supplement.

University of Groningen Recipient's Genetic R702W NOD2 Variant Is Associated with an Increased Risk of Bacterial Infections after Orthotopic Liver Transplantation Janse,

J. Ringers, H. Verspaget, R. Porte, 2013 .

Recipient’s Genetic R702W NOD2 Variant Is Associated with an Increased Risk of Bacterial Infections after Orthotopic Liver Transplantation

J. Ringers, R. Weersma, H. Verspaget, 2013, PloS one.

The Future Role of Anti-Tumour Necrosis Factor-α Products in the Treatment of Crohn's Disease

H. Verspaget, R. A. Hogezand, 2012, Drugs.

Attenuated mild colonic inflammation and improved survival from severe DSS-colitis of transgenic Cu/Zn-SOD mice.

H. Verspaget, F. Zijlstra, D. Jaarsma, 2003, Free radical biology & medicine.

Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease

H. Verspaget, S. Marklund, C. Lamers, 2003, The Journal of pathology.

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.

H. Verspaget, S. Ganesh, Cornelis F. M. Sier, 1993, Gut.

5-aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer

D. Hommes, D. Richel, H. Verspaget, 2011, Gut.

Homeostasis of the esophageal epithelium : A quest for the stem cell

D. Hommes, H. Verspaget, V. Jaks, 2015 .

Hedgehog signalling stimulates precursor cell accumulation and impairs epithelial maturation in the murine oesophagus

M. Kasper, D. Hommes, H. Verspaget, 2012, Gut.

TIME OF ADMINISTRATION AND DISEASE SEVERITY ARE KEY FACTORS IN ACHIEVING EFFICACY OF HUMAN BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS IN AN EXPERIMENTAL MODEL OF COLITIS

D. Hommes, H. Verspaget, I. Molendijk, 2016 .

Neuroenteric peptides affect natural killer activity by intestinal lamina propria mononuclear cells

H. Verspaget, C. Lamers, B. Hansen, 1993, Journal of Neuroimmunology.

Effects of CCK-8 and CCK-33 on human natural killer cell activity: studies on intestinal lamina propria and peripheral blood mononuclear cells.

H. Verspaget, C. Lamers, E. V. van Tol, 1993, Immunopharmacology.

Modulatory effects of VIP and related peptides from the gastrointestinal tract on cell mediated cytotoxicity against tumour cells in vitro.

H. Verspaget, C. Lamers, A. Peña, 1991, Immunological investigations.

Intravenous administration of bombesin in man stimulates natural killer cell activity against tumour cells

H. Verspaget, A. Masclee, C. Lamers, 1991, Neuropeptides.

Neuropeptide regulation of cell-mediated cytotoxicity against human tumor cells

H. Verspaget, C. Lamers, E. Tol, 1990, Neuropeptides.

Neutralizing antibodies against adeno‐associated viruses in inflammatory bowel disease patients: Implications for gene therapy

D. Hommes, H. Verspaget, H. Petry, 2011, Inflammatory bowel diseases.

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas.

H. Verspaget, G. Griffioen, J. Verheijen, 1987, Cancer research.

Pretreatment with Interferon‐γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis

D. Hommes, H. Verspaget, I. Molendijk, 2011, Stem cells.

Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature.

W. Bemelman, H. Keizer, H. Verspaget, 1999, European journal of gastroenterology & hepatology.

Plasminogen Activator Activity and Composition in Human Colorectal Carcinomas

H. Verspaget, G. Griffioen, J. Verheijen, 1987 .

Plasminogen Activators in the Intestine of Patients with Inflammatory Bowel Disease

H. Verspaget, J. Verheijen, G. Dooijewaard, 1988, Thrombosis and Haemostasis.

Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation

H. Verspaget, L. Trouw, C. van Kooten, 2016, Annals of the rheumatic diseases.

Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation.

P. de Knijff, H. Verspaget, I. Doxiadis, 2005, Gastroenterology.

Components of the plasminogen activation system in uveal melanoma—a clinico‐pathological study

P. Quax, H. Verspaget, U. Weidle, 1995, The Journal of pathology.

Plasminogen activators and inhibitor type 1 in neoplastic colonic tissue from patients with familial adenomatous polyposis.

H. Verspaget, F. Nagengast, S. Ganesh, 1995, British Journal of Cancer.

Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group

N. Perico, G. Remuzzi, H. Verspaget, 2009, Transplantation.

Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis.

D. Hommes, H. Verspaget, I. Molendijk, 2016, Journal of Crohn's & colitis.

Chapter 6 Role of Matrix Metalloproteinase , Tissue Inhibitor of Metalloproteinase and Tumor Necrosis Factor-Single Nucleotide Gene Polymorphisms in Inflammatory Bowel Disease Short title : Role of SNPs in IBD

D. Hommes, H. Verspaget, C. Lamers, 2009 .

Impaired local natural killer cell activity in human colorectal carcinomas

H. Verspaget, C. Lamers, S. Peña, 2004, Cancer Immunology, Immunotherapy.

Detection of cells with NK activity from histologically normal mucosa in relation to disease.

H. Verspaget, C. Lamers, A. Peña, 1995, Advances in experimental medicine and biology.

Normal inflammatory bowel disease mucosa conceals alterations in natural killer cell activity.

H. Verspaget, C. Lamers, A. Peña, 1992, Scandinavian journal of gastroenterology.

The CD56 adhesion molecule is the major determinant for detecting non‐major histocompatibility complex‐restricted cytotoxic mononuclear cells from the intestinal lamina propria

H. Verspaget, C. Lamers, E. V. van Tol, 1992, European journal of immunology.

204 Genetic and Mucosal Expression Analysis Shows Important Roles for JAK2 and MST1 in the Pathogenesis of Ulcerative Colitis and Identifies More Susceptibility Loci

C. Wijmenga, K. Faber, H. Boezen, 2009 .

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.

D. Hommes, H. Verspaget, C. Lamers, 2007, World journal of gastroenterology.

Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates

B. Mertens, H. Verspaget, J. Bosch, 2018, Clinical transplantation.

Seropositivity in Dutch Crohn's disease patients against primed nude mouse lymph nodes, and the difference with lymphocytotoxic antibodies.

H. Verspaget, E. Ruitenberg, H. C. Walvoort, 1986, Gut.

Chapter 2 M ucosal expression of bFGF , FGFR-1 and Syndecan-1 and their mRNA in Inflammatory Bowel Disease ( IBD ) Short title : bFGF complex in IBD

H. Verspaget, Q. Gao, H. Baelde, 2005 .

Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease

D. Hommes, H. Verspaget, C. Lamers, 2009, Inflammatory bowel diseases.

Chapter 7 Matrix Metalloproteinases and their Tissue Inhibitors as Prognostic Indicators for Diagnostic and Surgical Recurrence in Crohn ’ s Disease Short title : Recurrence in CD

D. Hommes, H. Verspaget, C. Lamers, 2009 .

MMP‐2 is a disease‐modifying gene in primary sclerosing cholangitis

R. Weersma, H. Verspaget, R. Porte, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase.

H. Ronday, H. Verspaget, J. Verheijen, 1997, The Biochemical journal.

Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.

H. Verspaget, I. Molendijk, A. van der Meulen-de Jong, 2018, Inflammatory bowel diseases.

Association of aneuploidy in index adenomas with metachronous colorectal adenoma development and a comparison

H. Verspaget, C. Cornelisse, F. Bosman, 1992, Cancer.

Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum.

H. Verspaget, F. Bosman, G. Griffioen, 1991, Gastroenterology.

Value of Registration in the Identification and Surveillance of Familial Adenomatous Polyposis in the Netherlands

H. Verspaget, F. Nagengast, G. Griffioen, 1990 .

Mucin profiles and potential for malignancy of human colorectal adenomatous polyps

H. Verspaget, F. Bosman, G. Griffioen, 1989, Cancer.

Plasminogen activators in (pre)malignant conditions of the colorectum.

H. Verspaget, G. Griffioen, J. Verheijen, 1989, European journal of cancer & clinical oncology.

H. Verspaget, C. Lamers, R. A. Hogezand, 2001 .

H. Verspaget, C. Lamers, R. A. Hogezand, 2001, American Journal of Gastroenterology.

Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity

H. Verspaget, F. Prins, A. Masclee, 2011, Scandinavian journal of gastroenterology.

Crohn's disease of the upper gastrointestinal tract.

H. Verspaget, G. Griffioen, C. Lamers, 1997, The Netherlands journal of medicine.

Crohn's disease in the elderly: a comparison with young adults.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1998, Journal of clinical gastroenterology.

Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease

H. Verspaget, G. Griffioen, C. Lamers, 1995, Alimentary pharmacology & therapeutics.

Effect of cortisol and ACTH on corticosteroid-suppressed peripheral blood natural killer cells from healthy volunteers and patients with Crohn's disease.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1996, Immunopharmacology.

Cytokine Mixtures Mimicking the Local Milieu in Patients with Inflammatory Bowel Disease Impact Phenotype and Function of Mesenchymal Stromal Cells

H. Verspaget, W. Fibbe, A. van der Meulen-de Jong, 2022, Stem cells translational medicine.

Short article: Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis

H. Verspaget, R. Jalan, R. Stauber, 2017, European journal of gastroenterology & hepatology.

Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis.

H. Verspaget, R. Jalan, R. Stauber, 2017, European journal of gastroenterology & hepatology.

The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer

D. Hommes, H. Verspaget, G. R. van den Brink, 2010, Carcinogenesis.

Allogeneic Bone Marrow L Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn ’ s Disease

D. Hommes, H. Verspaget, I. Molendijk, 2015 .

Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

D. Hommes, H. Verspaget, J. Verheijen, 2009, Cancer science.

UvA-DARE ( Digital Academic Repository ) Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide

H. Verspaget, C. Lamers, R. Veenendaal, 1998 .

Expression and ligand binding of bombesin receptors in pulmonary and intestinal carcinoids

H. Verspaget, C. Lamers, B. Taal, 2011, Journal of endocrinological investigation.

Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

C. Bosman, C. V. D. van de Velde, H. Verspaget, 1998, British Journal of Cancer.

ASSESSMENT OF SERUM MATRIX METALLOPROTEINASES MMP-2 AND MMP-9 AFTER HUMAN LIVER TRANSPLANTATION: INCREASED SERUM MMP-9 LEVEL IN ACUTE REJECTION

J. Ringers, H. Verspaget, Q. Gao, 2004, Transplantation.

Plasma MMP–2 and MMP–9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation

H. Verspaget, C. Legnani, G. Palareti, 2004, Thrombosis and Haemostasis.

Inhibition of intestinal macrophage chemotaxis to leukotriene B4 by sulphasalazine, olsalazine, and 5‐aminosalicylic acid

H. Verspaget, O. Nielsen, H. Verspaget, 1988, Alimentary pharmacology & therapeutics.

Prognostic value of plasminogen activators and their inhibitors in colorectal cancer.

H. Verspaget, S. Ganesh, Cornelis F. M. Sier, 1995, European journal of cancer.

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines.

P. Quax, H. Verspaget, J. Verheijen, 1990, Cancer research.

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.

H. Verspaget, G. Griffioen, J. Verheijen, 1989, British Journal of Cancer.

CHAPTER 4 Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

H. Verspaget, S. Ganesh, F. Kubben, 2007 .

Crohn's disease of the upper gastrointestinal tract: the value of endoscopic examination.

H. Verspaget, C. Lamers, R. Veenendaal, 1998, Scandinavian journal of gastroenterology. Supplement.

Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia

H. Verspaget, R. Veenendaal, J. V. van Dissel, 2005, Epidemiology and Infection.

Faecal parameters in the assessment of activity in inflammatory bowel disease.

H. Verspaget, C. Lamers, A. van der Sluys Veer, 1999, Scandinavian journal of gastroenterology. Supplement.

Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vitro analysis.

H. Verspaget, C. Lamers, A. Peña, 1991, Scandinavian journal of gastroenterology.

Metallothionein free radical scavenger and cardiovascular morbidity.

H. Verspaget, J. V. van Dissel, M. Frolich, 1997, European heart journal.

Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease.

H. Verspaget, C. Lamers, R. V. van Hogezand, 1997, The American journal of gastroenterology.

Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.

H. Verspaget, F. Kubben, G. Griffioen, 2007, European journal of cancer.

Short article: Absence of serological rheumatoid arthritis biomarkers in inflammatory bowel disease patients with arthropathies

D. M. van der Heijde, D. Hommes, H. Verspaget, 2017, European journal of gastroenterology & hepatology.

Impaired activation of the neutrophil oxidative metabolism in chronic inflammatory bowel disease.

H. Verspaget, C. Lamers, A. Peña, 1986, Scandinavian journal of gastroenterology.

ELISA assay for quantitative measurement of human immunoglobulins IgA, IgG, and IgM in nanograms.

H. Verspaget, A. Peña, P. L. Lems-van Kan, 1983, Journal of immunological methods.

Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectum

C. Fellbaum, H. Verspaget, M. Schmitt, 1991, Histopathology.

Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study.

D. M. van der Heijde, D. Hommes, H. Verspaget, 2016, Journal of Crohn's & colitis.

Isolation, characterization, and determination of human liver (copper/zinc) metallothionein

H. Verspaget, C. Lamers, A. Janssens, 1990, Experientia.

DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers

Timothy J. Yeatman, Robert N. Jorissen, Torben F. Ørntoft, 2008, Clinical Cancer Research.

Effect of zinc therapy on natural killer cell activity in inflammatory bowel disease

H. Verspaget, G. Griffioen, C. Lamers, 1993, Alimentary pharmacology & therapeutics.

Decreased natural killer cell activity in late-onset hypogammaglobulinaemia.

H. Verspaget, A. Peña, R. van Furth, 1990, Clinical science.

Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease.

Roeland A Veenendaal, Bert A Bonsing, Hein W Verspaget, 2015, Gastroenterology.

Human Cu/Zn Superoxide Dismutase (SOD1) Overexpression in Mice Causes Mitochondrial Vacuolization, Axonal Degeneration, and Premature Motoneuron Death and Accelerates Motoneuron Disease in Mice Expressing a Familial Amyotrophic Lateral Sclerosis Mutant SOD1

J. Holstege, H. Verspaget, D. Jaarsma, 2000, Neurobiology of Disease.

Local but not systemic administration of mesenchymal stromal cells ameliorates fibrogenesis in regenerating livers

H. Verspaget, I. Molendijk, B. van Hoek, 2019, Journal of cellular and molecular medicine.

Risk factors for infection after liver transplantation.

H. Verspaget, B. van Hoek, Bert-Jan de Rooij, 2012, Best practice & research. Clinical gastroenterology.

Contribution of plasma cortisol to corticosteroid-suppressed peripheral blood natural killer cell activity in Crohn's disease.

H. Verspaget, G. Griffioen, C. Lamers, 1995, Immunopharmacology.

High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Hailiang Huang, Stephan Ripke, Andre Franke, 2014, Nature Genetics.

Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

Judy H. Cho, C. Gieger, M. Daly, 2012 .

Collagen degradation and neutrophilic infiltration: a vicious circle in inflammatory bowel disease

A. Kraneveld, J. Garssen, H. Verspaget, 2013, Gut.

Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content.

H. Verspaget, C. Lamers, A. Peña, 1988, Gut.

Partial defect of neutrophil oxidative metabolism in Crohn's disease.

H. Verspaget, A. Peña, M. Mieremet-Ooms, 1984, Gut.

Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort

C. Wijmenga, D. Hommes, I. Nolte, 2008, Gut.

Is radiolabelled sucralphate scintigraphy of any use in the diagnosis of inflammatory bowel disease?

H. Verspaget, E. Pauwels, C. Lamers, 1988, Nuclear medicine communications.

CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma

H. Verspaget, L. Terracciano, B. van Hoek, 2018, The Journal of pathology.

Prospective comparative study of technetium-99m-WBCs and indium-111-granulocytes for the examination of patients with inflammatory bowel disease.

H. Verspaget, E. Pauwels, C. Lamers, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Value of Magnetic Resonance Cholangiopancreatography in Assessment of Nonanastomotic Biliary Strictures After Liver Transplantation

J. Ringers, H. Verspaget, B. van Hoek, 2015, Transplantation direct.

VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis.

Valérie Ferreira, Hein W Verspaget, D. Hommes, 2008, European journal of cancer.

Diminished expression of CRHR2 in human colon cancer promotes tumor growth and EMT via persistent IL-6/Stat3 signaling.

D. Iliopoulos, D. Hommes, H. Verspaget, 2015, Cellular and molecular gastroenterology and hepatology.

Diminished Expression of Corticotropin-Releasing Hormone Receptor 2 in Human Colon Cancer Promotes Tumor Growth and Epithelial-to-Mesenchymal Transition via Persistent Interleukin-6/Stat3 Signaling

D. Iliopoulos, D. Hommes, H. Verspaget, 2015, Cellular and Molecular Gastroenterology and Hepatology.

A new conditional Apc-mutant mouse model for colorectal cancer.

P. Devilee, H. Verspaget, R. Fodde, 2010, Carcinogenesis.

Mesenchymal stromal cells prevent progression of liver fibrosis in a novel zebrafish embryo model

H. Verspaget, B. Snaar-Jagalska, B. van Hoek, 2018, Scientific Reports.

Donor‐specific anti‐HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

H. Verspaget, R. Wolterbeek, D. Roelen, 2018, Clinical transplantation.

Clinical Application and Potential of Fecal Microbiota Transplantation.

E. Kuijper, J. Keller, H. Verspaget, 2019, Annual review of medicine.

MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.

D. Iliopoulos, T. Palumbo, D. Hommes, 2015, Gastroenterology.

Value of indium-111 granulocyte scintigraphy in the assessment of Crohn's disease of the small intestine: prospective investigation.

H. Verspaget, E. Pauwels, C. Lamers, 1988, Digestion.

Image quality and radiopharmaceutical parameters of Indium-111 granulocytes in scintigraphy of inflammatory bowel disease

H. Verspaget, E. Pauwels, C. Lamers, 2004, European Journal of Nuclear Medicine.

Value of indium-111 tropolonate autologous granulocyte scintigraphy in the assessment of inflammatory bowel disease.

H. Verspaget, E. Pauwels, C. Lamers, 1990, Scandinavian journal of gastroenterology. Supplement.

A Prospective Comparison of 99mTc-Labeled Polyclonal Human Immunoglobulin and 111In Granulocytes for Localization of Inflammatory Bowel Disease

H. Verspaget, E. Pauwels, G. Griffioen, 1992, Acta radiologica.

Technetium-99m nanocolloid for the scintigraphic assessment of inflammatory bowel disease in the colon: its value in comparison with indium-111-labelled granulocytes.

H. Verspaget, E. Pauwels, G. Griffioen, 1991, European journal of radiology.

The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC

R. Tollenaar, D. Geraets, D. Hommes, 2014, British Journal of Cancer.

Gastroduodenal Crohn's disease and pancreatitis.

H. Verspaget, Casper G Noomen, R. A. Veenendaal, 2008, Gastroenterology & hepatology.

TETRANECTIN AND PLASMIN/PLASMINOGEN ARE SIMILARLY DISTRIBUTED AT THE INVASIVE FRONT OF CUTANEOUS MELANOMA LESIONS

H. Verspaget, U. Weidle, E. Bröcker, 1996, The Journal of pathology.

Expression of somatostatin receptors in human pancreatic tumor.

H. Verspaget, C. Lamers, G. Offerhaus, 1998, Pancreas.

Proteases as prognostic markers in cancer

H. Verspaget, 1998, BMJ.

Preclinical Detection of Familial Adenomatous Polyposis: Fact or Fancy?

H. Verspaget, G. Griffioen, C. Lamers, 1989 .

The Dutch Pancreas Biobank Within the Parelsnoer Institute: A Nationwide Biobank of Pancreatic and Periampullary Diseases

M. Boermeester, G. Kazemier, P. Fockens, 2018, Pancreas.

Natural killer cell activity in patients with neuroendocrine tumours of the gastrointestinal tract; Relation with circulating gastrointestinal hormones

H. Verspaget, C. Lamers, A. Peña, 1991, Neuropeptides.

Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

H. Verspaget, A. Peña, J. Hafkenscheid, 1990, Gut.

Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation

J. Ringers, D. Hommes, H. Verspaget, 2010, Hepatology.

HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1

A. Zhernakova, C. Wijmenga, L. Franke, 2015, Genes and Immunity.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

A. Zhernakova, C. Wijmenga, H. Völzke, 2014, Gastroenterology.

How to: Establish and run a stool bank.

C. Mulder, E. van Nood, E. Kuijper, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Liver chimerism after allogeneic blood stem cell transplantation.

H. Verspaget, C. Lamers, B. van Hoek, 2007, Transplantation proceedings.

Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II

Frits Koning, Allan Thompson, Yuching Lai, 2012, Gut.

Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro

Mogens Kruhøffer, Francisco Mansilla, L. Aaltonen, 2007, Molecular oncology.

Are activity indices helpful in assessing active intestinal inflammation in Crohn's disease?

H. Verspaget, E. Pauwels, C. Lamers, 1989, Gut.

Radioprotection of colorectal cancer cells by 5-aminosalicylic acid

D. Hommes, H. Verspaget, P. Koelink, 2009 .

Mannose-binding lectin and ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation.

D. Hommes, H. Verspaget, B. van Hoek, 2011, Journal of hepatology.

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease

C. Wijmenga, T. Ahmad, P. Rutgeerts, 2013, Gut.

Contribution of CD3+CD8- and CD3+CD8+ T Cells to TNF-α Overexpression in Crohn Disease-Associated Perianal Fistulas and Induction of Epithelial-Mesenchymal Transition in HT-29 Cells.

G. Rogler, H. Verspaget, M. Spalinger, 2020, Inflammatory bowel diseases.

Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.

H. Verspaget, A. Masclee, P. P. J. van der Veek, 2005, The American journal of gastroenterology.

Genetic variants of innate immunity receptors are associated with mortality in cirrhotic patients with bacterial infection

H. Verspaget, R. Jalan, S. Zeuzem, 2020, Liver international : official journal of the International Association for the Study of the Liver.

5-ASA and colorectal cell-cycle progression.

H. Verspaget, P. Koelink, 2007, Gastroenterology.

The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's disease.

H. Verspaget, R. V. van Hogezand, 1998, Drugs.

Toll-like receptor 6 stimulation promotes T-helper 1 and 17 responses in gastrointestinal-associated lymphoid tissue and modulates murine experimental colitis

A. Kraneveld, H. Verspaget, G. Adema, 2014, Mucosal Immunology.

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)‐2 and ‐9 in Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2007, Inflammatory bowel diseases.

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

C. V. D. van de Velde, H. Verspaget, S. Ganesh, 1997, British Journal of Cancer.

Glutathione S-Transferase TTin Colorectal Tumors Is Predictive for Overall Survival1

Cornelis, H. Verspaget, S. Ganesh, 2006 .

Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.

J. Ringers, H. Verspaget, C. Lamers, 2003, Transplantation proceedings.

Endoglin shedding in colorectal cancer

D. Hommes, H. Verspaget, P. Dijke, 2009 .

A case of recurrent gastrinoma in the liver with a review of “primary” hepatic gastrinomas

H. Verspaget, C. Lamers, I. Biemond, 2009, BMJ Case Reports.

Copeptin is an independent prognostic factor for transplant‐free survival in cirrhosis

H. Verspaget, B. Hoek, M. Coenraad, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Standardization of mesenchymal stromal cell therapy for perianal fistulizing Crohn’s disease

D. Hommes, H. Verspaget, I. Molendijk, 2018, European journal of gastroenterology & hepatology.

Natural killer cell activity in patients with adenocarcinoma in the upper gastrointestinal tract.

H. Verspaget, C. Lamers, A. Peña, 1991, Journal of clinical & laboratory immunology.

Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease

J. Keller, H. Verspaget, G. Ianiro, 2023, Therapeutic advances in gastroenterology.

Cohort profile: design and first results of the Dutch IBD Biobank: a prospective, nationwide biobank of patients with inflammatory bowel disease

D. Hommes, R. Weersma, D. D. de Jong, 2017, BMJ Open.

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.

H. Verspaget, R. Jalan, F. Durand, 2016, Journal of hepatology.

Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis

F. Nevens, H. Verspaget, R. Wolterbeek, 2015, PloS one.

Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer.

H. Verspaget, C. Lamers, A. Janssens, 1992, Journal of hepatology.

Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas.

H. Verspaget, G. Griffioen, C. Lamers, 1998, Scandinavian journal of gastroenterology. Supplement.

Hemodynamic response to primary prophylactic therapy with nonselective &bgr;-blockers is related to a reduction of first variceal bleeding risk in liver cirrhosis: a meta-analysis

T. Stijnen, H. Verspaget, B. van Hoek, 2017, European journal of gastroenterology & hepatology.

Effect of the anti‐tumor necrosis factor‐&agr; antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

H. Verspaget, J. Verheijen, C. Lamers, 2007, Inflammatory bowel diseases.

Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidants

H. Verspaget, C. Lamers, L. Kruidenier, 2003, The Journal of pathology.

Chapter 3 Effect of the Anti-Tumor Necrosis Factor-Antibody Infliximab on the ex vivo Mucosal Matrix Metalloproteinase-Proteolytic Phenotype in Inflammatory Bowel Disease ( IBD ) Short title : Infliximab and MMPs in IBD

H. Verspaget, J. Verheijen, C. Lamers, 2009 .

Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas

D. Hommes, H. Verspaget, I. Molendijk, 2019, Journal of Crohn's & colitis.

5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model.

P. Devilee, D. Hommes, H. Verspaget, 2009, Carcinogenesis.

Very rapid anti-inflammatory effect of anti-TNF-a (RemicadeTM) in croun's disease as assessed by 99mTc-WBC-scintigraphy

H. Verspaget, G. Griffioen, J. Arndt, 2000 .

Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.

H. Verspaget, I. Molendijk, G. Dijkstra, 2018, Journal of Crohn's & colitis.

Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

D. Hommes, H. Verspaget, Cornelis F. M. Sier, 2011, World journal of gastrointestinal oncology.

Diagnostic Efficacy of the Secretin Stimulation Test for the Zollinger-Ellison Syndrome: An Intra-Individual Comparison Using Different Dosages in Patients and Controls

H. Verspaget, A. Masclee, C. Lamers, 2010, Pancreatology.

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival

H. Verspaget, R. Jalan, F. Durand, 2017, Critical Care.

Faecal microbiota transplantation influences procarcinogenic Escherichia coli in recipient recurrent Clostridioides difficile patients.

E. Kuijper, J. Keller, H. Verspaget, 2021, Gastroenterology.

Leucocyte matrix metalloproteinase (MMP)-9 gene and protein regulation in Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2003 .

Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma

H. Verspaget, J. Verheijen, C. Lamers, 2003, Thrombosis and Haemostasis.

Genetic Analysis in A Dutch Study Sample Identifies More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk

Cleo C. van Diemen, C. Wijmenga, H. Boezen, 2010, The American Journal of Gastroenterology.

Chapter 3 Liver chimerism after allogeneic blood stem cell transplantation

Bart, H. Verspaget, C. Lamers, 2011 .

Mucosal gelatinases MMP-2 and MMP-9 in Helicobacter pylori-associated gastritis

H. Verspaget, F. Kubben, J. Verheijen, 2007 .

Prognostic Significance of Metallothionein in Human Gastrointestinal Cancer 1

Cornelis J H van de Velde, Hein W Verspaget, C. V. D. van de Velde, 2002 .

Metallothionein in human gastrointestinal cancer

C. V. D. van de Velde, H. Verspaget, G. Griffioen, 2000, The Journal of pathology.

Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study.

J. Keller, H. Verspaget, J. van Prehn, 2020, The Lancet. Infectious diseases.

The expression of receptors for vasoactive intestinal peptide and secretin in colon neoplasms

H. Verspaget, C. Lamers, Chengwei Tang, 2001 .

The Parelsnoer Institute: A National Network of Standardized Clinical Biobanks in the Netherlands

H. Verspaget, R. Stolk, G. Zielhuis, 2017 .

Ten-Year Follow-Up of Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection from a Randomized Controlled Trial and Review of the Literature

E. van Nood, M. Dijkgraaf, J. Keller, 2021, Microorganisms.

A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group

H. Tilg, F. Mégraud, A. Gasbarrini, 2020, United European gastroenterology journal.

Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease

Schipper, C. Wijmenga, D. Hommes, 2011, PloS one.

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.

H. Verspaget, C. Lamers, R. V. van Hogezand, 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Matrix metalloproteinases in inflammatory bowel disease

H. Verspaget, C. Lamers, M. Meijer, 2000 .

Tumorigenic behaviour of c-Ha-ras oncogene transfected CaCo 2 cells is associated with increased proteolytic potency.

H. Verspaget, F. Bosman, J. D. de Vries, 1996, Anticancer research.

Human Transmission of Blastocystis by Fecal Microbiota Transplantation Without Development of Gastrointestinal Symptoms in Recipients

E. van Nood, E. Kuijper, M. Dijkgraaf, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sequential Liver Chemistry Profiling and Abdominal Ultrasound Assessments to Predict Biliary Strictures after Liver Transplantation

J. Ringers, H. Verspaget, R. Wolterbeek, 2012 .

M2073 NOD2/CARD15, Toll-Like Receptor 4, and Toll-Like Receptor 9 Gene Polymorphisms in Spanish and Dutch Patients with Inflammatory Bowel Disease

M. Sans, H. Verspaget, J. Panés, 2008 .

Veiled cells in chronic idiopathic inflammatory bowel disease.

H. Verspaget, H. Drexhage, S. Meuwissen, 1984, Clinical and experimental immunology.

Disordered regulation of the in vitro immunoglobulin synthesis by intestinal mononuclear cells in Crohn's disease.

H. Verspaget, C. Lamers, A. Peña, 1988, Gut.

Differences in the immunoglobulin synthesis by peripheral blood lymphocytes in Crohn's disease and ulcerative colitis.

H. Verspaget, C. Lamers, A. Peña, 1987, Digestion.

Local administration of mesenchymal stromal cells is safe and modulates the immune compartment in ulcerative proctitis

H. Verspaget, F. Koning, D. Roelen, 2023, JCI insight.

Plasminogen activators innormal tissue and carcinomas ofthehumanoesophagus andstomach

H. Verspaget, H. Vloedgraven, W. Lamers, 1993 .

Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease.

D. Hommes, H. Verspaget, I. Molendijk, 2011, Cytotherapy.

Development of a radioimmunoassay for human metallothionein.

H. Verspaget, C. Lamers, A. Janssens, 1990, Journal of immunological methods.

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

P. Quax, H. Verspaget, S. Ganesh, 1993, Invasion & metastasis.

In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.

H. Verspaget, C. Lamers, A. Peña, 1989, Journal of clinical & laboratory immunology.

Glutathione S-transferases in liver metastases of colorectal cancer. A comparison with normal liver and primary carcinomas.

H. Verspaget, Cornelis F. M. Sier, W. Peters, 1994, Carcinogenesis.

Mesenchymal Stromal Cell–Derived Exosomes Contribute to Epithelial Regeneration in Experimental Inflammatory Bowel Disease

H. Verspaget, E. Bos, L. Plug, 2020, Cellular and molecular gastroenterology and hepatology.

High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis

Judy H. Cho, C. Gieger, H. Hakonarson, 2015 .

Increased proportion of CD16+ NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment

M. Altfeld, B. Gazzard, G. Nuovo, 2010, Alimentary pharmacology & therapeutics.

Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs.

H. Verspaget, G. Griffioen, C. Lamers, 2000, Scandinavian Journal of Gastroenterology, Supplement.

Circulating cell death products predict clinical outcome of colorectal cancer patients

D. Hommes, H. Verspaget, C. Lamers, 2009, BMC Cancer.

120TiP Conversion of response to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: A randomized phase Ib/IIa trial

J. Keller, H. Verspaget, J. Haanen, 2022, Immuno-Oncology and Technology.

Determination of matrilysin activity in gastrointestinal neoplasia

H. Verspaget, R. Hanemaaijer, A. Langers, 2007, European journal of clinical investigation.

Chimerism as assessed by matrix metalloproteinase genotyping after orthotopic liver transplantation

Kerem, Coenraad, H. Verspaget, 2011 .

Prognostic significance of metallothionein in human gastrointestinal cancer.

H. Verspaget, F. Kubben, G. Griffioen, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

INFLAMMATORY BOWEL DISEASE Genetic Analysis in A Dutch Study Sample Identifi es More Ulcerative Colitis Susceptibility Loci and Shows Their Additive Role in Disease Risk

C. Wijmenga, D. Hommes, A. Franke, 2010 .

Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer

T. Ørntoft, L. Aaltonen, M. Kruhøffer, 2009, British Journal of Cancer.

Diagnostic Efficacy of the Secretin Stimulation Test for the Zollinger-Ellison Syndrome: An Intra-Individual Comparison Using Different Dosages in Patients and Controls

H. Verspaget, A. Masclee, C. Lamers, 2010, Pancreatology.

Quality-Assured Biobanking: The Leiden University Medical Center Model.

Rianne Haumann, Hein W Verspaget, H. Verspaget, 2018, Methods in molecular biology.

A new conditional Apc-mutant mouse model for colorectal cancer.

P. Devilee, H. Verspaget, R. Fodde, 2010, Carcinogenesis.

Oxidative stress as a pathogenic factor in inflammatory bowel disease — radicals or ridiculous?

H. Verspaget, L. Kruidenier, H. Verspaget, 2002, Alimentary pharmacology & therapeutics.

Author affiliations

H. Verspaget, B. Hoek, M. V. D. Berg, 2011, Canadian Medical Association Journal.

Mesalazine‐induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?

Griffioen, I. Nagtegaal, H. Verspaget, 1999, Alimentary pharmacology & therapeutics.

Real-life data on the impact of successful downstaging in patients with hepatocellular carcinoma: A Dutch Multicenter Study.

H. Verspaget, K. V. van Erpecum, B. van Hoek, 2021, European journal of internal medicine.